Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2025

医薬品開発業務受託機関(CRO)サービスの世界市場予測:種類別(検出、CMC、前臨床、臨床研究、実験室サービス)、治療領域別(腫瘍、CNS、循環器)、エンドユーザー別(医薬品、医療機器)

◆タイトル:Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2025
◆商品コード:PH 4672
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年4月30日
◆ページ数:268
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は医薬品開発業務受託機関(CRO)サービスの世界市場が、2020年477.7憶ドルから2025年737.7憶ドルまで、年平均9.1%成長すると予測しています。本調査レポートでは、医薬品開発業務受託機関(CRO)サービスの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、産業インサイト、サービス別(初期開発サービス、臨床研究サービス、実験室サービス、コンサルティングサービス、データ管理サービス)分析、治療領域別(腫瘍、中枢神経系、心血管、呼吸器、感染症、自己免疫疾患、糖尿病、その他)分析、エンドユーザー別(医薬品、医療機器)分析、地域別分析、競争状況、企業概要などを含め、今後の方向性を提示しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・産業インサイト
・医薬品開発業務受託機関(CRO)サービスの世界市場:サービス別(初期開発サービス、臨床研究サービス、実験室サービス、コンサルティングサービス、データ管理サービス)
・医薬品開発業務受託機関(CRO)サービスの世界市場:治療領域別(腫瘍、中枢神経系、心血管、呼吸器、感染症、自己免疫疾患、糖尿病、その他)
・医薬品開発業務受託機関(CRO)サービスの世界市場:エンドユーザー別(医薬品、医療機器)
・医薬品開発業務受託機関(CRO)サービスの世界市場:地域別
・競争状況
・企業概要

“The Contract Research Organization (CRO) services market is projected to grow at a CAGR of 9.1% between 2020 and 2025.”
The CRO services market is expected to reach USD 73.77 billion by 2025 from USD 47.77 billion in 2020, at a CAGR of 9.1% from 2020 to 2025. Increased outsourcing of R&D activities and an increasing number of clinical trials are some of the major factors driving the growth of this market. However, lack of skilled labor in the CRO services market is one of the major challenges for the players operating in CROs market.

“Data management services segment to witness the highest growth rate during the forecast period.”
Among the CRO services, the laboratory services segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing outsourcing of data management services by pharmaceutical and biopharmaceutical companies.

“Oncology segment to grow at the highest CAGR from 2020 to 2025.”
The oncology segment is expected to grow at the highest CAGR during the forecast period. The increasing number of clinical trials and the rising prevalence of cancer worldwide are the major factors supporting its growth during the forecast period.

“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapid growth in the pharmaceutical and biopharmaceutical industry, low cost of clinical trials, rising number of CROs, and favorable government policies in the region.

Break of primary participants:
• By Company Type – Tier 1: 42%, Tier 2–13%, and Tier 3–45%
• By Designation – C Level: 17%, Director Level: 25%, and Others: 58%
• By Region – North America: 20%, Europe: 28%, Asia Pacific: 18%, Latin America: 25%, and the Middle East & Africa: 9%

Research Coverage:
The report analyzes the various CRO services and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global CRO services market for different segments such as type, therapeutic area, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.

The report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the service portfolios offered by the top players in the CRO services market
 Service Launch/Innovation: Detailed insights on new service launches in the CRO services market
 Market Development: Comprehensive information about lucrative emerging markets, by type, therapeutic area, end user, and region
 Market Diversification: Exhaustive information about new services, growing geographies, recent developments in the CRO services market
 Competitive Assessment: In-depth assessment of growth strategies, services, and manufacturing capabilities of leading players in the CRO services market

【レポートの目次】

1 Introduction
1.1 Objectives of study
1.2 Market definition
1.3 Market scope
1.3.1 Markets covered
1.3.2 Years considered for the study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research approach
2.2 Market size estimation
2.3 Market breakdown and data triangulation
2.4 Market share estimation
2.4.1 Key data from secondary sources
2.5 Key data from primary sources
2.5.1 Key Industry Insights
2.6 Assumptions for the study

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growing R&D expenditures
5.3.1.2 Increased outsourcing of R&D activities
5.3.1.3 Increasing demand of outsourcing analytical testing and clinical trial services
5.3.1.4 Increase in clinical trials
5.3.2 Restraints
5.3.2.1 Regulatory pressure on CROs
5.3.3 Opportunities
5.3.3.1 Growing biosimilars and biologics market
5.3.3.2 Rising demand for specialized testing services
5.3.4 Challenges
5.3.4.1 Growing competition in the CRO industry
5.3.4.2 Regulatory pressure on pharma and medical device manufacturers to drive more detailed chemical analysis of drugs, and devices
5.3.4.3 Shortage of skilled professionals

6 Industry Insight
6.1 Industry Trends
6.1.1 Growing consolidation in the CROs industry
6.1.2 Globalization of clinical trials
6.1.3 Increasing demnad of outsourcing various services and preferred vendor partnerships
6.1.4 Technological Advancement

7 Contract Research Organization Market, By Services
7.1 Introduction
7.2 Early Phase Development Services
7.2.1 Discovery Studies
7.2.2 Chemistry, Manufacturing & Control
7.2.3 Preclinical
7.2.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)
7.2.3.2 Toxicology Testing
7.2.3.3 Other Preclinical Services
7.3 Clinical Research Services
7.3.1 Phase I
7.3.2 Phase II
7.3.3 Phase III
7.3.4 Phase IV
7.4 Laboratory Services
7.4.1 Bioanalytical Testing
7.4.2 Analytical Testing
7.4.2.1 Physical Characterization
7.4.2.2 Stability Testing
7.4.2.3 Batch Release Testing
7.4.2.4 Raw Material Testing
7.4.2.5 Other Analytical Testing
7.5 Consulting Services
7.6 Data Management Services

8 Contract Research Organization Market, By Therapeutic Areas
8.1 Oncology
8.2 Central Nervous System
8.3 Cardiovascular
8.4 Respiratory
8.5 Infectious Diseases
8.6 Autoimmune Disorders
8.7 Diabetes
8.8 Others

9 Contract Research Organization Market, By End User
9.1 Pharmaceutical and Biopharmaceutical Companies
9.2 Medical Device Companies
9.3 Academic Institutes

10 Geographic Analysis
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 APAC
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 RoAPAC
10.4.5 Latin America
10.4.6 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation & Trends
11.3.1 Agreements, collaborations, joint ventures, and partnerships
11.3.2 Expansions
11.3.3 Mergers and acquisitions
11.3.4 New Service launches

12 Company Profiles
12.1 IQVIA
12.2 LabCorp
12.3 Charles river Laboratories
12.4 WuXi Apptec
12.5 Syneos Health Inc.
12.6 Paraxel International
12.7 PRA Health Sciences
12.8 PPD
12.9 ICON Plc
12.10 Medpace Holdings
12.11 SGS
12.12 PSI CRO AG
12.13 Axcent Advanced Analytics (A3)
12.14 BIO Agile Therapeutics
12.15 Firma Clinical Research
12.16 Acculab Lifesciences
12.17 Azelix
12.18 CTSERV
12.19 PEPGRA
12.20 Dove Quality Solutions

13 Appendix
13.1 Insights of industry experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: MarketsandMarkets’ Subscription Portal
13.5 Available customizations
13.6 Introducing RT: Real Time Market Intelligence



★調査レポート[医薬品開発業務受託機関(CRO)サービスの世界市場予測:種類別(検出、CMC、前臨床、臨床研究、実験室サービス)、治療領域別(腫瘍、CNS、循環器)、エンドユーザー別(医薬品、医療機器)] ( Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2025 / PH 4672) 販売に関する免責事項
[医薬品開発業務受託機関(CRO)サービスの世界市場予測:種類別(検出、CMC、前臨床、臨床研究、実験室サービス)、治療領域別(腫瘍、CNS、循環器)、エンドユーザー別(医薬品、医療機器)] ( Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2025 / PH 4672) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆